Filing Details
- Accession Number:
- 0001387131-20-005521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-08 16:07:40
- Reporting Period:
- 2020-06-05
- Accepted Time:
- 2020-06-08 16:07:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532235 | G Robert Finizio | 951 Yamato Road, Suite 220 Boca Raton FL 33431 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-05 | 10,000 | $1.16 | 18,335,964 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-06-05 | 20,000 | $1.15 | 18,355,964 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,004,941 | Indirect | See Footnote |
| Common Stock | 995,059 | Indirect | See Footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (2) to this Form 4.
- The reported securities are owned by the reporting person's Grantor-Retained Annuity Trust.
- The reported securities are owned by Robert Finizio Revocable Trust.
Billionaire Hedge Funds
